106 related articles for article (PubMed ID: 37001364)
1. Generation of a set of induced pluripotent stem cell lines from two Alzheimer disease patients carrying APOE4 (MLUi007-J; MLUi008-A) and healthy old donors carrying APOE3 (MLUi009-A; MLUi010-B) to study APOE in aging and disease.
Jung M; Hartmann C; Ehrhardt T; Peter LM; Abid CL; Harwardt B; Hirschfeld J; Claus C; Haferkamp U; Pless O; Nastainczyk-Wulf M; Kehlen A; Schlote D; Schroder IS; Rujescu D
Stem Cell Res; 2023 Jun; 69():103072. PubMed ID: 37001364
[TBL] [Abstract][Full Text] [Related]
2. Generation of the Human iPSC Line from Spontaneous Late-Onset Alzheimer's Disease Patient with ApoE3/3 Genotype and Sex-, Age-, and ApoE-Matched Healthy Control.
Kadakova S; Raska J; Hribkova H; Fedorova V; Sedmik J; Plesingrova K; Sheardova K; Bohaciakova D
Stem Cell Res; 2024 Feb; 74():103273. PubMed ID: 38100913
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant.
Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
Stem Cell Res; 2017 Dec; 25():266-269. PubMed ID: 29246571
[TBL] [Abstract][Full Text] [Related]
4. Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell Plasticity.
Jung M; Jung JS; Pfeifer J; Hartmann C; Ehrhardt T; Abid CL; Kintzel J; Puls A; Navarrete Santos A; Hollemann T; Riemann D; Rujescu D
Mol Neurobiol; 2024 Mar; 61(3):1562-1579. PubMed ID: 37728850
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A).
Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
Stem Cell Res; 2018 Oct; 32():145-149. PubMed ID: 30296667
[TBL] [Abstract][Full Text] [Related]
6. Establishment of SIAISi021-A, an induced pluripotent stem cell (iPSC) line from a 71-year-old Chinese Han male with Alzheimer's Disease (AD) having two copies of APOE4/4 allele.
Ding Y; Chen H; Zhao J; Wang Y; Deng Y
Stem Cell Res; 2022 Aug; 63():102866. PubMed ID: 35843023
[TBL] [Abstract][Full Text] [Related]
7. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant.
Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
Stem Cell Res; 2017 Oct; 24():160-163. PubMed ID: 29034886
[TBL] [Abstract][Full Text] [Related]
8. Establishment of TUSMi003-A, an induced pluripotent stem cell (iPSC) line from a 62-year old Chinese Han patient with Alzheimer's disease with ApoE3/4 genetic background.
Wang Y; Yu H; Zhang Y; Zhang J; Chen K; Sun H; Meng S; Li G; Lei Y; Zhao J
Stem Cell Res; 2018 Mar; 27():57-60. PubMed ID: 29328972
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells derived from one 70-years-old male donor with the APOE-ε4/ε4 alleles.
Wang J; Liu X; Du X; Ma Z; Liu B; Guo R; Feng B; Ma J; Cui H
Stem Cell Res; 2021 May; 53():102395. PubMed ID: 34088020
[TBL] [Abstract][Full Text] [Related]
10. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids.
Zhao J; Fu Y; Yamazaki Y; Ren Y; Davis MD; Liu CC; Lu W; Wang X; Chen K; Cherukuri Y; Jia L; Martens YA; Job L; Shue F; Nguyen TT; Younkin SG; Graff-Radford NR; Wszolek ZK; Brafman DA; Asmann YW; Ertekin-Taner N; Kanekiyo T; Bu G
Nat Commun; 2020 Nov; 11(1):5540. PubMed ID: 33139712
[TBL] [Abstract][Full Text] [Related]
11. Blood-derived integration-free iPS cell line UKBi011-A from a diagnosed male Alzheimer's disease patient with APOE ɛ4/ɛ4 genotype.
Peitz M; Bechler T; Thiele CC; Veltel M; Bloschies M; Fliessbach K; Ramirez A; Brüstle O
Stem Cell Res; 2018 May; 29():250-253. PubMed ID: 29753274
[TBL] [Abstract][Full Text] [Related]
12. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes.
de Leeuw SM; Kirschner AWT; Lindner K; Rust R; Budny V; Wolski WE; Gavin AC; Nitsch RM; Tackenberg C
Stem Cell Reports; 2022 Jan; 17(1):110-126. PubMed ID: 34919811
[TBL] [Abstract][Full Text] [Related]
13. Human induced pluripotent stem cell (iPSC) line (HEBHMUi014-A) derived from a patient with Alzheimer's disease.
Zhang M; Yu M; Guo R; Zhang Y; Zhang X; Sun J; Zhang J; Wang X; Ma J
Stem Cell Res; 2023 Jun; 69():103116. PubMed ID: 37178573
[TBL] [Abstract][Full Text] [Related]
14. Integration-free induced pluripotent stem cell line derived from a 62-years-old male donor with APOE-epsilon4/epsilon4 alleles.
Guo R; Liu X; Zhang J; Ma X; Gou D; Ma Z; Wang L; Ma J; Cui H
Stem Cell Res; 2022 May; 61():102746. PubMed ID: 35305470
[TBL] [Abstract][Full Text] [Related]
15. Interaction of ApoE3 and ApoE4 isoforms with an ITM2b/BRI2 mutation linked to the Alzheimer disease-like Danish dementia: Effects on learning and memory.
Biundo F; Ishiwari K; Del Prete D; D'Adamio L
Neurobiol Learn Mem; 2015 Dec; 126():18-30. PubMed ID: 26528887
[TBL] [Abstract][Full Text] [Related]
16. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
17.
Sienski G; Narayan P; Bonner JM; Kory N; Boland S; Arczewska AA; Ralvenius WT; Akay L; Lockshin E; He L; Milo B; Graziosi A; Baru V; Lewis CA; Kellis M; Sabatini DM; Tsai LH; Lindquist S
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658354
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cell line (IPTi002-A) from an 87-year old sporadic Alzheimer's disease patient with APOE3 (ε3/ε3) genotype.
Zhang L; Ren Q; Liu X; Liu G; Meng S; Xiahou K; Zhang Y; Jiang N; Zhou W
Stem Cell Res; 2021 May; 53():102282. PubMed ID: 33799279
[TBL] [Abstract][Full Text] [Related]
20. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
